Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes

Publication Journal of the American College of Cardiology (JACC)

Study in JACC examines finerenone’s effects on cardiorenal outcomes in patients with type 2 diabetes and chronic kidney disease, offering new insights for treatment.


Read the article